Roche announced that it has completed the acquisition of cent per cent of the issued and outstanding shares and warrants of Arius Research. On September 19th, the Ontario Superior Court, Canada, approved the plan of arrangement previously approved by the security holders and announced ....
The details can be read here.
No comments:
Post a Comment